Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 1/20 | 0.57 |
| ▸ | HRH1 | P35367 | 2/20 | 0.53 |
| ▸ | GHSR | Q92847 | 1/20 | 0.50 |
| ▸ | CDYL2 | Q8N8U2 | 1/20 | 0.49 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31181287 | 0.91 | GNPAT (0.54) | FURINGHSROPRK1MMP2 | |
| SCHEMBL7588115 | 0.89 | OPRK1 (0.49) | FURINCDYL2CDYLOPRK1MMP2 | |
| SCHEMBL7592267 | 0.88 | OPRD1 (0.49) | OPRK1MMP2 | |
| SCHEMBL7592268 | 0.88 | OPRD1 (0.49) | OPRK1MMP2 | |
| SCHEMBL30099540 | 0.87 | MMP2 (0.56) | FURINGHSROPRK1MMP2 | |
| SCHEMBL20964469 | 0.87 | CTSL (0.49) | GHSROPRK1MMP2QRFPR | |
| SCHEMBL31528247 | 0.86 | OPRK1 (0.60) | FURINOPRK1 | |
| SCHEMBL29446993 | 0.86 | OPRK1 (0.60) | FURINOPRK1 | |
| SCHEMBL29972565 | 0.86 | CTSL (0.51) | GHSROPRK1MMP2QRFPR | |
| SCHEMBL31554972 | 0.85 | MMP2 (0.56) | FURINOPRK1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4316595-A2 | USE OF CGRP RECEPTOR ANTAGONISTS IN TREATING GLAUCOMA | Soares, Christopher, J. (US) | 2024-02-07 | — | — | EP | disclosed |